Clinical Trials Browser

INDUSTRY × HR-positive, HER2-negative Advanced Breast Cancer × Clear all

NCT06950086 2025-04-29

Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

HR-positive, HER2-negative Advanced Breast Cancer

NCT04796623 2021-03-15

A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast Cancer

Phase 2 Unknown

HR-positive, HER2-negative Advanced Breast Cancer